Genetic evidence that HNF-1alpha-dependent transcriptional control of HNF-4alpha is essential for human pancreatic beta cell function
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Genetic evidence that HNF-1alpha-dependent transcriptional control of HNF-4alpha is essential for human pancreatic beta cell function. / Hansen, Sara K; Párrizas, Marcelina; Jensen, Maria L; Pruhova, Stepanka; Ek, Jakob; Boj, Sylvia F; Johansen, Anders; Maestro, Miguel A; Rivera, Francisca; Eiberg, Hans; Andel, Michal; Lebl, Jan; Pedersen, Oluf; Ferrer, Jorge; Hansen, Torben.
In: Journal of Clinical Investigation, Vol. 110, No. 6, 2002, p. 827-33.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Genetic evidence that HNF-1alpha-dependent transcriptional control of HNF-4alpha is essential for human pancreatic beta cell function
AU - Hansen, Sara K
AU - Párrizas, Marcelina
AU - Jensen, Maria L
AU - Pruhova, Stepanka
AU - Ek, Jakob
AU - Boj, Sylvia F
AU - Johansen, Anders
AU - Maestro, Miguel A
AU - Rivera, Francisca
AU - Eiberg, Hans
AU - Andel, Michal
AU - Lebl, Jan
AU - Pedersen, Oluf
AU - Ferrer, Jorge
AU - Hansen, Torben
PY - 2002
Y1 - 2002
N2 - Mutations in the genes encoding hepatocyte nuclear factor 4alpha (HNF-4alpha) and HNF-1alpha impair insulin secretion and cause maturity onset diabetes of the young (MODY). HNF-4alpha is known to be an essential positive regulator of HNF-1alpha. More recent data demonstrates that HNF-4alpha expression is dependent on HNF-1alpha in mouse pancreatic islets and exocrine cells. This effect is mediated by binding of HNF-1alpha to a tissue-specific promoter (P2) located 45.6 kb upstream from the previously characterized Hnf4alpha promoter (P1). Here we report that the expression of HNF-4alpha in human islets and exocrine cells is primarily mediated by the P2 promoter. Furthermore, we describe a G --> A mutation in a conserved nucleotide position of the HNF-1alpha binding site of the P2 promoter, which cosegregates with MODY. The mutation results in decreased affinity for HNF-1alpha, and consequently in reduced HNF-1alpha-dependent activation. These findings provide genetic evidence that HNF-1alpha serves as an upstream regulator of HNF-4alpha and interacts directly with the P2 promoter in human pancreatic cells. Furthermore, they indicate that this regulation is essential to maintain normal pancreatic function.
AB - Mutations in the genes encoding hepatocyte nuclear factor 4alpha (HNF-4alpha) and HNF-1alpha impair insulin secretion and cause maturity onset diabetes of the young (MODY). HNF-4alpha is known to be an essential positive regulator of HNF-1alpha. More recent data demonstrates that HNF-4alpha expression is dependent on HNF-1alpha in mouse pancreatic islets and exocrine cells. This effect is mediated by binding of HNF-1alpha to a tissue-specific promoter (P2) located 45.6 kb upstream from the previously characterized Hnf4alpha promoter (P1). Here we report that the expression of HNF-4alpha in human islets and exocrine cells is primarily mediated by the P2 promoter. Furthermore, we describe a G --> A mutation in a conserved nucleotide position of the HNF-1alpha binding site of the P2 promoter, which cosegregates with MODY. The mutation results in decreased affinity for HNF-1alpha, and consequently in reduced HNF-1alpha-dependent activation. These findings provide genetic evidence that HNF-1alpha serves as an upstream regulator of HNF-4alpha and interacts directly with the P2 promoter in human pancreatic cells. Furthermore, they indicate that this regulation is essential to maintain normal pancreatic function.
KW - Adolescent
KW - Adult
KW - Animals
KW - Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
KW - Child
KW - Child, Preschool
KW - DNA-Binding Proteins
KW - Diabetes Mellitus, Type 2
KW - Female
KW - Genes, Reporter
KW - Hepatocyte Nuclear Factor 1
KW - Hepatocyte Nuclear Factor 1-alpha
KW - Hepatocyte Nuclear Factor 1-beta
KW - Hepatocyte Nuclear Factor 4
KW - Humans
KW - Infant
KW - Islets of Langerhans
KW - Male
KW - Mutation
KW - Nuclear Proteins
KW - Pedigree
KW - Phosphoproteins
KW - Promoter Regions, Genetic
KW - Receptors, Glucocorticoid
KW - Transcription Factors
KW - Transcription, Genetic
U2 - 10.1172/JCI15085
DO - 10.1172/JCI15085
M3 - Journal article
C2 - 12235114
VL - 110
SP - 827
EP - 833
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
SN - 0021-9738
IS - 6
ER -
ID: 38457884